Show simple item record

dc.contributor.authorBond, Reiss
dc.date.accessioned2019-08-14T08:36:52Z
dc.date.available2019-08-14T08:36:52Z
dc.date.issued2018-11
dc.identifier.citationBond, R., 2018. Tourniquets in the treatment of prehospital haemorrhage. Journal of Paramedic Practice, 10 (11), 477-487.en_US
dc.identifier.issn1759-1376
dc.identifier.issn2041-9457
dc.identifier.doi10.12968/jpar.2018.10.11.477
dc.identifier.urihttp://hdl.handle.net/20.500.12417/132
dc.description.abstractAbstract published with permission. Background: During recent conflicts in Iraq and Afghanistan, tourniquets were a useful tool in the management of non-compressible prehospital catastrophic haemorrhage. Recommendations for use within the civilian setting were then made. However, civilian research supporting this change in practice is limited. Aims: The aim of the research is to evaluate the utility of prehospital tourniquet application through description of the complications associated with use, as well as identification of mortality following prehospital application. Methods: A literature search was completed using PubMed and Embase for research studies on prehospital tourniquet use in extremity trauma. Study relevance was confirmed via their abstracts and final selection was made through reviewing the full publication. Data were extracted on mortality, complications, indication for use, effective application and application duration of tourniquet use. This was tabulated, and a descriptive analysis performed. Results: The research reported a mortality range of 3–14% with an associated complication rate of 2.1–32.4%. The effectiveness of prehospital application was in the 88.8–98.7% range, with tourniquet application durations of 48–103.2 minutes. Conclusions: The tourniquet should continue to be available to UK paramedics for the management of prehospital non-compressible catastrophic haemorrhage. Application is likely to provide a mortality benefit with limited morbidity and associated complications.
dc.language.isoenen_US
dc.subjectEmergency Medical Servicesen_US
dc.subjectTourniqueten_US
dc.subjectCatastrophic Haemorrhageen_US
dc.subjectTraumaen_US
dc.subjectPre-hospital Careen_US
dc.titleTourniquets in the treatment of prehospital haemorrhageen_US
dc.source.journaltitleJournal of Paramedic Practiceen_US
dcterms.dateAccepted2019-07-17
rioxxterms.versionNAen_US
rioxxterms.versionofrecord10.12968/jpar.2018.10.11.477en_US
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden_US
rioxxterms.licenseref.startdate2019-07-17
rioxxterms.typeJournal Article/Reviewen_US
refterms.panelUnspecifieden_US
refterms.dateFirstOnline2018-11
html.description.abstractAbstract published with permission. Background: During recent conflicts in Iraq and Afghanistan, tourniquets were a useful tool in the management of non-compressible prehospital catastrophic haemorrhage. Recommendations for use within the civilian setting were then made. However, civilian research supporting this change in practice is limited. Aims: The aim of the research is to evaluate the utility of prehospital tourniquet application through description of the complications associated with use, as well as identification of mortality following prehospital application. Methods: A literature search was completed using PubMed and Embase for research studies on prehospital tourniquet use in extremity trauma. Study relevance was confirmed via their abstracts and final selection was made through reviewing the full publication. Data were extracted on mortality, complications, indication for use, effective application and application duration of tourniquet use. This was tabulated, and a descriptive analysis performed. Results: The research reported a mortality range of 3–14% with an associated complication rate of 2.1–32.4%. The effectiveness of prehospital application was in the 88.8–98.7% range, with tourniquet application durations of 48–103.2 minutes. Conclusions: The tourniquet should continue to be available to UK paramedics for the management of prehospital non-compressible catastrophic haemorrhage. Application is likely to provide a mortality benefit with limited morbidity and associated complications.en_US


This item appears in the following Collection(s)

Show simple item record